Lv1
90 积分 2024-04-11 加入
The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies
4天前
已完结
The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies
4天前
已完结
Safety and pharmacokinetics evaluation of oroxylin A in Chinese healthy volunteers: a phase I, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect study
9天前
已完结
Monoclonal antibody-induced cytokine-release syndrome
13天前
已完结
Monoclonal antibody-induced cytokine-release syndrome
13天前
已关闭
Image reconstruction parameters and the standardized uptake value ratios in brain amyloid PET
17天前
已完结
First-in-human evaluation of [211At]YF2 in patients with metastatic castration-resistant prostate cancer
19天前
已完结
Omeprazole: A Study of Its Inhibition of Gastric pH and Oral Pharmacokinetics After Morning or Evening Dosage
26天前
已完结
Standardization of PET imaging and site qualification program by JSNM: collaboration with EANM/EARL
1个月前
已完结
The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non‐Small‐Cell Lung Cancer and in Healthy Volunteers
2个月前
已完结
皖公网安备34019202002308
